Totaligent, INC

Totaligent, Inc. has entered into a definitive agreement to acquire the assets of Aetherium Medical, appointing Ivan Klarich as President and a board member.

Totaligent, Inc. has extended the target date for its proposed acqui-hire transaction with Aetherium Medical to April 10, 2026, to allow for additional due diligence and negotiations.

Totaligent, Inc. announced an extension to the binding letter of intent with Aetherium Medical, pushing the target closing date for their proposed acqui-hire transaction to March 20, 2026.

Totaligent, Inc. has entered a binding letter of intent to form a joint venture with GloMed Solutions Limited Liability Company to expand its Aetherium Medical platform into high-growth APAC markets, alongside a call option to acquire GloMed.

Totaligent, Inc. has entered a binding letter of intent to acquire Aetherium Medical's team, intellectual property, and assets in an all-equity acqui-hire transaction.

Totaligent, Inc. has entered into a six-month agreement with 247MarketNews for investor and public relations services, compensating the consultant with 5 million shares of restricted common stock.

Totaligent, Inc. filed its Q1 2026 10-Q, detailing a net loss of $108,090 and a strategic pivot towards AI integration and potential acquisitions, while facing ongoing going concern risks.

Totaligent, Inc. reported a significant revenue decline and increased net loss for the nine months ended September 30, 2025, raising substantial doubt about its ability to continue as a going concern.

Totaligent, Inc. reported no revenue for the six months ended June 30, 2025, alongside a significant net loss and a going concern warning, despite progress on its digital marketing platform.

Totaligent, Inc. reports a net loss for Q1 2025 with a decrease in revenue due to reduced managed campaign activity, while launching its consumer-facing digital marketing platform.

Totaligent's Q1 2025 results show a decrease in revenue due to reduced managed campaign activity, alongside a net loss, as the company focuses on its newly launched consumer-facing digital marketing platform.

Totaligent, Inc. experienced revenue growth in Q3 2024, but also saw a significant increase in operating expenses, leading to a larger net loss compared to the same period last year.

Totaligent, Inc. is strategically evolving its digital marketing platform to integrate AI, explore acquisitions, and re-enter cryptocurrency mining, while reporting a significant revenue decrease for fiscal year 2025.

Totaligent, Inc. files an amendment to its 2024 annual report to correct certain items and expand disclosures in the Subsequent Events section.

Totaligent, Inc. reports a net loss for 2024 as it focuses on launching its integrated digital marketing platform, shifting from managed campaigns to a consumer-facing model.

Totaligent, Inc., a technology company, filed its annual 10-K report, detailing its person-based digital marketing platform and plans for a public launch in Q1 2025.

Totaligent, Inc. files an amended registration statement for the resale of up to 100,000,000 shares of common stock by Joint Effort Funding, LLC.

Totaligent, Inc. has filed a registration statement for the resale of up to 100 million shares of its common stock by Joint Effort Funding, LLC, under a standby equity purchase agreement.